首页 > 最新文献

Journal of the Formosan Medical Association最新文献

英文 中文
Efficacy of jing Si herbal tea in functional dyspepsia: A double-blind, randomized, placebo-controlled study. 京四凉茶对功能性消化不良的疗效:一项双盲、随机、安慰剂对照研究。
IF 3.2 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-09 DOI: 10.1016/j.jfma.2024.09.008
Chin-Hung Liu,Fang-Cen Tu,Ming-Wun Wong,Jui-Sheng Hung,Chih-Hsun Yi,Tso-Tsai Liu,Wei-Yi Lei,Chien-Lin Chen
BACKGROUNDFunctional dyspepsia (FD) is prevalent worldwide and is associated with gastrointestinal inflammation, mucosal anomalies, and shifts in microbiota metabolites like short chain fatty acids. This study assesses the efficacy of Jing Si herbal tea (JSHT) in alleviating FD symptoms, psychological distress, and influencing metabolites.METHODSAdults with FD based on Rome IV criteria were included. Participants underwent physical and psychological evaluations, pre-treatment blood sampling, and were randomly assigned to JSHT or placebo groups for four weeks. Post-treatment, evaluations and Liquid Chromatography-Mass Spectrometry for gut metabolites were done. Successful response was defined by a 50% symptom reduction. Symptom intensity, sleep, depression, anxiety, and stress were measured using questionnaires.RESULTS26 patients (median age 55.5 years, range 22-77 years, 60.6% female) were studied. Both JSHT and placebo groups were similar at baseline. JSHT showed a higher response rate (69.2%) than placebo (23.1%, P = 0.018). JSHT recipients experienced notable reduction in upper gastrointestinal symptoms and anxiety (P = 0.005; P = 0.037). Increased serum butyrate was observed in improved patients (P = 0.01), whereas no major changes were detected in the placebo group.CONCLUSIONFour weeks of JSHT treatment ameliorated FD symptoms and anxiety, potentially linked to increased serum butyrate. This study suggests that JSHT has potential therapeutic role in patients with FD.
背景功能性消化不良(FD)在全球普遍存在,与胃肠道炎症、粘膜异常和短链脂肪酸等微生物群代谢物的变化有关。本研究评估了静思凉茶(JSHT)在缓解 FD 症状、心理压力和影响代谢物方面的功效。参与者接受身体和心理评估、治疗前抽血,并被随机分配到 JSHT 或安慰剂组,为期四周。治疗后进行评估,并用液相色谱-质谱法检测肠道代谢物。成功应答的定义是症状减轻 50%。研究对象为 26 名患者(中位年龄 55.5 岁,22-77 岁,60.6% 为女性)。JSHT 组和安慰剂组的基线相似。JSHT 的应答率(69.2%)高于安慰剂(23.1%,P = 0.018)。JSHT 受试者的上消化道症状和焦虑明显减轻(P = 0.005;P = 0.037)。结论4 周的 JSHT 治疗可改善 FD 症状和焦虑,这可能与血清丁酸盐的增加有关。这项研究表明,JSHT 对 FD 患者具有潜在的治疗作用。
{"title":"Efficacy of jing Si herbal tea in functional dyspepsia: A double-blind, randomized, placebo-controlled study.","authors":"Chin-Hung Liu,Fang-Cen Tu,Ming-Wun Wong,Jui-Sheng Hung,Chih-Hsun Yi,Tso-Tsai Liu,Wei-Yi Lei,Chien-Lin Chen","doi":"10.1016/j.jfma.2024.09.008","DOIUrl":"https://doi.org/10.1016/j.jfma.2024.09.008","url":null,"abstract":"BACKGROUNDFunctional dyspepsia (FD) is prevalent worldwide and is associated with gastrointestinal inflammation, mucosal anomalies, and shifts in microbiota metabolites like short chain fatty acids. This study assesses the efficacy of Jing Si herbal tea (JSHT) in alleviating FD symptoms, psychological distress, and influencing metabolites.METHODSAdults with FD based on Rome IV criteria were included. Participants underwent physical and psychological evaluations, pre-treatment blood sampling, and were randomly assigned to JSHT or placebo groups for four weeks. Post-treatment, evaluations and Liquid Chromatography-Mass Spectrometry for gut metabolites were done. Successful response was defined by a 50% symptom reduction. Symptom intensity, sleep, depression, anxiety, and stress were measured using questionnaires.RESULTS26 patients (median age 55.5 years, range 22-77 years, 60.6% female) were studied. Both JSHT and placebo groups were similar at baseline. JSHT showed a higher response rate (69.2%) than placebo (23.1%, P = 0.018). JSHT recipients experienced notable reduction in upper gastrointestinal symptoms and anxiety (P = 0.005; P = 0.037). Increased serum butyrate was observed in improved patients (P = 0.01), whereas no major changes were detected in the placebo group.CONCLUSIONFour weeks of JSHT treatment ameliorated FD symptoms and anxiety, potentially linked to increased serum butyrate. This study suggests that JSHT has potential therapeutic role in patients with FD.","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":null,"pages":null},"PeriodicalIF":3.2,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142212292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of shared decision-making in Taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapy. 共同决策对符合新型口服抗凝剂治疗条件的台湾心房颤动患者的影响。
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-07 DOI: 10.1016/j.jfma.2024.08.036
Yen-Wen Wu, Tsung-Hsien Lin, Yuan-Po Yang, Wei-Tsung Wu, Chung-Ming Tu, Hung-Kain Huang, Chun-Yuan Chu, Chi-Cheng Huang, Szu-Chi Chien, Shih-Jie Jhuo, Ching-Pei Chen

Background/purpose: Shared decision-making (SDM) promotes patient awareness about medical conditions and treatments, facilitating patient involvement in care decisions. This two-stage multicenter study evaluated impacts of SDM in Taiwanese adults with atrial fibrillation (AF) eligible for novel oral anticoagulant (NOAC) therapy.

Methods: Participants were NOAC-naïve (part I) or dabigatran-experienced (part II). During Stage I, part I participants (n = 124) completed a semi-structured survey (understanding evaluation sections only) before and after viewing SDM materials on stroke prevention for AF. Surveys collected data on anxiety about AF, confidence in healthcare professionals, usefulness of the SDM materials, and perception of different NOACs. During Stage II, part I participants after being prescribed NOACs, and part II participants completed another survey to compare impacts of SDM.

Results: During Stage I, dabigatran was the preferred NOAC after viewing the SDM materials among 90% of part I participants. During Stage II, both part I (n = 87) and part II participants (n = 104) completed another survey. Fewer part I participants were anxious about AF (p < 0.01), and more had confidence in healthcare professionals (p < 0.01) after viewing SDM materials than before. Most part I participants (≥90%) rated the SDM materials as "very helpful". In Stage II, participants viewing SDM before initiating dabigatran had lower anxiety (part I, 43%; part II, 53%; p < 0.01) and a higher trust (part I, 92%; part II, 84%; p < 0.01).

Conclusion: In conclusion, SDM reduced anxiety and improved trust in healthcare professionals among NOAC-naïve participants with AF.

背景/目的:共同决策(SDM)可提高患者对病情和治疗的认识,促进患者参与护理决策。这项分两个阶段进行的多中心研究评估了 SDM 对符合新型口服抗凝剂(NOAC)治疗条件的台湾成年房颤患者的影响:方法: 参与研究者均为 NOAC 患者(第一阶段)或有达比加群治疗经验者(第二阶段)。在第一阶段,第一部分参与者(n = 124)在观看有关房颤卒中预防的 SDM 资料前后完成了一份半结构化调查(仅评估理解部分)。调查收集的数据包括对房颤的焦虑、对医护人员的信心、SDM 资料的实用性以及对不同 NOAC 的看法。在第二阶段,第一部分参与者在获得 NOACs 处方后,第二部分参与者完成了另一项调查,以比较 SDM 的影响:结果:在第一阶段,90% 的第一部分参与者在观看 SDM 资料后首选达比加群为 NOAC。在第二阶段,第一部分参与者(87 人)和第二部分参与者(104 人)都完成了另一项调查。第一部分参与者中对房颤感到焦虑的人数较少(P总之,SDM 降低了患有房颤的 NOAC 患者的焦虑感,提高了他们对医护人员的信任度。
{"title":"Impact of shared decision-making in Taiwanese patients with atrial fibrillation eligible for novel oral anticoagulant therapy.","authors":"Yen-Wen Wu, Tsung-Hsien Lin, Yuan-Po Yang, Wei-Tsung Wu, Chung-Ming Tu, Hung-Kain Huang, Chun-Yuan Chu, Chi-Cheng Huang, Szu-Chi Chien, Shih-Jie Jhuo, Ching-Pei Chen","doi":"10.1016/j.jfma.2024.08.036","DOIUrl":"https://doi.org/10.1016/j.jfma.2024.08.036","url":null,"abstract":"<p><strong>Background/purpose: </strong>Shared decision-making (SDM) promotes patient awareness about medical conditions and treatments, facilitating patient involvement in care decisions. This two-stage multicenter study evaluated impacts of SDM in Taiwanese adults with atrial fibrillation (AF) eligible for novel oral anticoagulant (NOAC) therapy.</p><p><strong>Methods: </strong>Participants were NOAC-naïve (part I) or dabigatran-experienced (part II). During Stage I, part I participants (n = 124) completed a semi-structured survey (understanding evaluation sections only) before and after viewing SDM materials on stroke prevention for AF. Surveys collected data on anxiety about AF, confidence in healthcare professionals, usefulness of the SDM materials, and perception of different NOACs. During Stage II, part I participants after being prescribed NOACs, and part II participants completed another survey to compare impacts of SDM.</p><p><strong>Results: </strong>During Stage I, dabigatran was the preferred NOAC after viewing the SDM materials among 90% of part I participants. During Stage II, both part I (n = 87) and part II participants (n = 104) completed another survey. Fewer part I participants were anxious about AF (p < 0.01), and more had confidence in healthcare professionals (p < 0.01) after viewing SDM materials than before. Most part I participants (≥90%) rated the SDM materials as \"very helpful\". In Stage II, participants viewing SDM before initiating dabigatran had lower anxiety (part I, 43%; part II, 53%; p < 0.01) and a higher trust (part I, 92%; part II, 84%; p < 0.01).</p><p><strong>Conclusion: </strong>In conclusion, SDM reduced anxiety and improved trust in healthcare professionals among NOAC-naïve participants with AF.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142154456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive genomic profiling in multiple cancer types: A comparative analysis of the National Biobank Consortium of Taiwan and clinical practice cohorts. 多种癌症类型的综合基因组图谱分析:台湾国家生物库联盟与临床实践队列的比较分析。
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-06 DOI: 10.1016/j.jfma.2024.09.001
Ling-Jen Hung, Chen-Yang Huang, Kai-Che Tung, Jen-Shi Chen, Wen-Kuan Huang, Chih-Chung Hsu, Yueh-Fu Fang, Chih-Liang Wang, Ping-Chi Liu, Kun-Yun Yeh, Pei-Hung Chang, John Wen-Cheng Chang, Yung-Chang Lin, Shiu-Feng Huang, Wen-Chi Chou

Background: This retrospective study analyzed tumor tissue profiling data to assess the potential of comprehensive genomic profiling (CGP) for patient care across diverse solid tumors.

Material and methods: Patients with newly diagnosed or recurrent stage IIIB or IV lung adenocarcinoma with a null immunophenotype and esophageal, gastric, pancreatic, or bile duct cancer between January 2020 and July 2023 at two medical centers in Taiwan were included. One cohort was a part of the National Biobank Consortium of Taiwan project, whereas the other consisted of patients undergoing routine clinical practice. Tumor samples were subjected to CGP using FoundationOne®CDx, with therapeutic implications determined using OncoKB classification.

Results: FoundationOne®CDx testing of 574 patients was successful in 456 (79.4%) patients. Clinically actionable genomic alterations were detected in 21.1% (96/456) of the patients, including 17.5%, 2.9%, and 0.7% of patients with evidence levels 1, 2, and 3, respectively. Lung adenocarcinoma accounted for the largest proportion of samples with at least one actionable gene alteration (63.2%), followed by bile duct (26.9%), gastric (17.6%), esophageal (4.0%), and pancreatic (3.1%) cancers. Based on CGP results, 43 patients (9.4%) received matched targeted therapy. The median overall survival of patients who received matched therapy or not was 26.1 months (95% confidence interval (CI), 16.7-35.5 months) and 10.6 months (95% CI, 8.1-13.1 months; hazard ratio, 0.28, 95% CI, 0.14-0.55, p < 0.001), respectively.

Conclusions: This study provides comprehensive insights into the genomic profiles of diverse cancers in Taiwan, highlighting the crucial role of CGP in identifying actionable genomic alterations and guiding effective therapeutic strategies in real-world practice.

背景这项回顾性研究分析了肿瘤组织图谱数据,以评估综合基因组图谱(CGP)在不同实体瘤患者护理方面的潜力:纳入2020年1月至2023年7月期间在台湾两家医疗中心新诊断或复发的免疫表型为空的IIIB或IV期肺腺癌以及食管癌、胃癌、胰腺癌或胆管癌患者。其中一个群组是台湾国家生物库联盟项目的一部分,而另一个群组则由接受常规临床实践的患者组成。使用FoundationOne®CDx对肿瘤样本进行CGP检测,并使用OncoKB分类确定治疗意义:结果:对 574 名患者进行的 FoundationOne®CDx 检测在 456 名(79.4%)患者中获得成功。在 21.1%(96/456)的患者中检测到了临床可操作的基因组改变,其中证据等级为 1、2 和 3 的患者分别占 17.5%、2.9% 和 0.7%。在至少有一个可操作基因改变的样本中,肺腺癌所占比例最大(63.2%),其次是胆管癌(26.9%)、胃癌(17.6%)、食管癌(4.0%)和胰腺癌(3.1%)。根据CGP结果,43名患者(9.4%)接受了匹配的靶向治疗。接受匹配治疗或未接受匹配治疗的患者的中位总生存期分别为26.1个月(95%置信区间(CI),16.7-35.5个月)和10.6个月(95% CI,8.1-13.1个月;危险比为0.28,95% CI,0.14-0.55,P 结论:本研究全面揭示了台湾不同癌症的基因组特征,突出了 CGP 在识别可操作的基因组改变和指导实际有效治疗策略方面的关键作用。
{"title":"Comprehensive genomic profiling in multiple cancer types: A comparative analysis of the National Biobank Consortium of Taiwan and clinical practice cohorts.","authors":"Ling-Jen Hung, Chen-Yang Huang, Kai-Che Tung, Jen-Shi Chen, Wen-Kuan Huang, Chih-Chung Hsu, Yueh-Fu Fang, Chih-Liang Wang, Ping-Chi Liu, Kun-Yun Yeh, Pei-Hung Chang, John Wen-Cheng Chang, Yung-Chang Lin, Shiu-Feng Huang, Wen-Chi Chou","doi":"10.1016/j.jfma.2024.09.001","DOIUrl":"https://doi.org/10.1016/j.jfma.2024.09.001","url":null,"abstract":"<p><strong>Background: </strong>This retrospective study analyzed tumor tissue profiling data to assess the potential of comprehensive genomic profiling (CGP) for patient care across diverse solid tumors.</p><p><strong>Material and methods: </strong>Patients with newly diagnosed or recurrent stage IIIB or IV lung adenocarcinoma with a null immunophenotype and esophageal, gastric, pancreatic, or bile duct cancer between January 2020 and July 2023 at two medical centers in Taiwan were included. One cohort was a part of the National Biobank Consortium of Taiwan project, whereas the other consisted of patients undergoing routine clinical practice. Tumor samples were subjected to CGP using FoundationOne®CDx, with therapeutic implications determined using OncoKB classification.</p><p><strong>Results: </strong>FoundationOne®CDx testing of 574 patients was successful in 456 (79.4%) patients. Clinically actionable genomic alterations were detected in 21.1% (96/456) of the patients, including 17.5%, 2.9%, and 0.7% of patients with evidence levels 1, 2, and 3, respectively. Lung adenocarcinoma accounted for the largest proportion of samples with at least one actionable gene alteration (63.2%), followed by bile duct (26.9%), gastric (17.6%), esophageal (4.0%), and pancreatic (3.1%) cancers. Based on CGP results, 43 patients (9.4%) received matched targeted therapy. The median overall survival of patients who received matched therapy or not was 26.1 months (95% confidence interval (CI), 16.7-35.5 months) and 10.6 months (95% CI, 8.1-13.1 months; hazard ratio, 0.28, 95% CI, 0.14-0.55, p < 0.001), respectively.</p><p><strong>Conclusions: </strong>This study provides comprehensive insights into the genomic profiles of diverse cancers in Taiwan, highlighting the crucial role of CGP in identifying actionable genomic alterations and guiding effective therapeutic strategies in real-world practice.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mediating effect of loneliness on the associations of perceived and internalized sexual stigma with suicide in gay and bisexual men. 孤独感对男同性恋者和双性恋者感知到的和内在化的性污名与自杀之间关系的中介效应。
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-05 DOI: 10.1016/j.jfma.2024.08.030
Po-Chun Lin, Yu-Ping Chang, Yi-Lung Chen, Cheng-Fang Yen

Background/purpose: Loneliness is prevalent among gay and bisexual men (GBM). This study evaluated the mediating effect of loneliness on the associations of perceived sexual stigma (PSS) and internalized sexual stigma (ISS) with suicide in 400 GBM.

Methods: A moderated mediation model was used to test the mediating effects of loneliness between the associations of PSS from family members and ISS with suicide and the moderating effects of sexual orientation, age, and education level on the mediating effects.

Results: The results indicated that both PSS and ISS were positively associated with suicide through the full mediation of loneliness. The association of ISS with loneliness was stronger in older GBM.

Conclusions: Intervention programs promoting changes in attitudes toward GBM are warranted to prevent the development of PSS and ISS, loneliness, and suicide in this population.

背景/目的:孤独感在男同性恋者和双性恋者(GBM)中十分普遍。本研究评估了孤独感对感知到的性污名(PSS)和内化的性污名(ISS)与 400 名男同性恋者自杀之间关系的中介效应:方法:采用调节中介模型检验孤独感在家庭成员的性鄙视(PSS)和内化性鄙视(ISS)与自杀之间的中介效应,以及性取向、年龄和教育水平对中介效应的调节作用:结果表明,通过孤独感的完全中介作用,PSS 和 ISS 均与自杀呈正相关。ISS与孤独感的关系在年龄较大的GBM中更为密切:结论:有必要制定干预计划,促进改变对 GBM 的态度,以防止该人群出现 PSS 和 ISS、孤独和自杀。
{"title":"Mediating effect of loneliness on the associations of perceived and internalized sexual stigma with suicide in gay and bisexual men.","authors":"Po-Chun Lin, Yu-Ping Chang, Yi-Lung Chen, Cheng-Fang Yen","doi":"10.1016/j.jfma.2024.08.030","DOIUrl":"https://doi.org/10.1016/j.jfma.2024.08.030","url":null,"abstract":"<p><strong>Background/purpose: </strong>Loneliness is prevalent among gay and bisexual men (GBM). This study evaluated the mediating effect of loneliness on the associations of perceived sexual stigma (PSS) and internalized sexual stigma (ISS) with suicide in 400 GBM.</p><p><strong>Methods: </strong>A moderated mediation model was used to test the mediating effects of loneliness between the associations of PSS from family members and ISS with suicide and the moderating effects of sexual orientation, age, and education level on the mediating effects.</p><p><strong>Results: </strong>The results indicated that both PSS and ISS were positively associated with suicide through the full mediation of loneliness. The association of ISS with loneliness was stronger in older GBM.</p><p><strong>Conclusions: </strong>Intervention programs promoting changes in attitudes toward GBM are warranted to prevent the development of PSS and ISS, loneliness, and suicide in this population.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the pulmonary venous entry site morphology on postoperative pulmonary vein stenosis in total anomalous pulmonary venous connection patients. 肺静脉入口部位形态对全异常肺静脉连接患者术后肺静脉狭窄的影响。
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-05 DOI: 10.1016/j.jfma.2024.09.006
Szu-Yen Hu, Jing-Ren Ye, Heng-Wen Chou, Yih-Sharng Chen, Chung-I Chang, Ing-Sh Chiu, Chih-Ting Lin, Hsiao-En Tsai, Shyh-Jye Chen, Shu-Chien Huang

Background: To evaluate the association between the pulmonary vein (PV) entry site morphology after total anomalous pulmonary vein repair (TAPVC) and postoperative pulmonary vein stenosis (PVS).

Methods: Computed tomography (CT) examination was performed to determine the PV entry site morphology. The width of the PV confluence was divided by the width of the left atrium (LA) to obtain the cPV/LA index. The cPV/LA index was compared between patients with and without postoperative PVS.

Results: Fifty-one patients who had undergone CT after TAPVC repair were included, with a median cPV/LA index of 0.5 (interquartile range (IQR) = 0.349-0.654). Among them, 27 patients developed postoperative PVS. The median cPV/LA index after primary TAPVC repair was significantly lower in patients with PVS compared to those without PVS (0.367, IQR = 0.308-0.433 vs. 0.657, IQR = 0.571-0.783, P < 0.0001). Additionally, the cPV/LA index after surgical re-intervention for PVS was significantly smaller in patients who developed recurrent stenosis compared to those who remained free-from re-stenosis after surgical relief (0.459, IQR = 0.349-0.556; vs. 0.706, IQR = 0.628-0.810, P = 0.0045).

Conclusion: A small PV confluence width is associated with the development of postoperative PVS and recurrent stenosis after surgical relief of PVS. Our results suggest that adequate bilateral pulmonary vein lateralization during TAPVC surgery is crucial.

背景:评估全肺静脉异常修补术(TAPVC)后肺静脉(PV)入口部位形态与术后肺静脉狭窄(PVS)之间的关系:方法:通过计算机断层扫描(CT)检查确定肺静脉入口部位的形态。将 PV 汇合处的宽度除以左心房(LA)的宽度,得出 cPV/LA 指数。对术后出现和未出现 PVS 的患者的 cPV/LA 指数进行比较:结果:共纳入了 51 名在 TAPVC 修复术后接受 CT 检查的患者,中位 cPV/LA 指数为 0.5(四分位距 (IQR) = 0.349-0.654)。其中,27 名患者术后出现了 PVS。与无 PVS 的患者相比,有 PVS 的患者在 TAPVC 初级修复术后的中位 cPV/LA 指数明显较低(0.367,IQR = 0.308-0.433 vs. 0.657,IQR = 0.571-0.783, P 结论:PVS 患者的中位 cPV/LA 指数较低:较小的肺静脉汇合宽度与术后发生 PVS 和手术解除 PVS 后复发狭窄有关。我们的研究结果表明,在 TAPVC 手术中进行充分的双侧肺静脉侧切至关重要。
{"title":"Impact of the pulmonary venous entry site morphology on postoperative pulmonary vein stenosis in total anomalous pulmonary venous connection patients.","authors":"Szu-Yen Hu, Jing-Ren Ye, Heng-Wen Chou, Yih-Sharng Chen, Chung-I Chang, Ing-Sh Chiu, Chih-Ting Lin, Hsiao-En Tsai, Shyh-Jye Chen, Shu-Chien Huang","doi":"10.1016/j.jfma.2024.09.006","DOIUrl":"https://doi.org/10.1016/j.jfma.2024.09.006","url":null,"abstract":"<p><strong>Background: </strong>To evaluate the association between the pulmonary vein (PV) entry site morphology after total anomalous pulmonary vein repair (TAPVC) and postoperative pulmonary vein stenosis (PVS).</p><p><strong>Methods: </strong>Computed tomography (CT) examination was performed to determine the PV entry site morphology. The width of the PV confluence was divided by the width of the left atrium (LA) to obtain the cPV/LA index. The cPV/LA index was compared between patients with and without postoperative PVS.</p><p><strong>Results: </strong>Fifty-one patients who had undergone CT after TAPVC repair were included, with a median cPV/LA index of 0.5 (interquartile range (IQR) = 0.349-0.654). Among them, 27 patients developed postoperative PVS. The median cPV/LA index after primary TAPVC repair was significantly lower in patients with PVS compared to those without PVS (0.367, IQR = 0.308-0.433 vs. 0.657, IQR = 0.571-0.783, P < 0.0001). Additionally, the cPV/LA index after surgical re-intervention for PVS was significantly smaller in patients who developed recurrent stenosis compared to those who remained free-from re-stenosis after surgical relief (0.459, IQR = 0.349-0.556; vs. 0.706, IQR = 0.628-0.810, P = 0.0045).</p><p><strong>Conclusion: </strong>A small PV confluence width is associated with the development of postoperative PVS and recurrent stenosis after surgical relief of PVS. Our results suggest that adequate bilateral pulmonary vein lateralization during TAPVC surgery is crucial.</p>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to comment on Chinese herbal medicine compound of flavonoids adjunctive treatment for oral cancer. 对 "中药复方黄酮类化合物辅助治疗口腔癌 "评论的回复
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-05 DOI: 10.1016/j.jfma.2024.09.004
Yi-Chiung Hsu
{"title":"Reply to comment on Chinese herbal medicine compound of flavonoids adjunctive treatment for oral cancer.","authors":"Yi-Chiung Hsu","doi":"10.1016/j.jfma.2024.09.004","DOIUrl":"https://doi.org/10.1016/j.jfma.2024.09.004","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142145867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Effect of tibolone versus hormone replacement therapy on lower urinary tract symptoms and sexual function". 就 "替勃龙与激素替代疗法对下尿路症状和性功能的影响 "发表评论。
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-03 DOI: 10.1016/j.jfma.2024.08.022
Rui-Jun Wang, Zhang Yi, Shuang-Yao Wang, Xi-Ren Ji
{"title":"Comment on \"Effect of tibolone versus hormone replacement therapy on lower urinary tract symptoms and sexual function\".","authors":"Rui-Jun Wang, Zhang Yi, Shuang-Yao Wang, Xi-Ren Ji","doi":"10.1016/j.jfma.2024.08.022","DOIUrl":"https://doi.org/10.1016/j.jfma.2024.08.022","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142133041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to “Impact of pretreatment quality of life on tolerance and survival outcome in head and neck cancer patients undergoing definitive CCRT” 回复 "治疗前生活质量对接受最终 CCRT 的头颈癌患者耐受性和生存结果的影响"。
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.1016/j.jfma.2024.03.001
{"title":"Reply to “Impact of pretreatment quality of life on tolerance and survival outcome in head and neck cancer patients undergoing definitive CCRT”","authors":"","doi":"10.1016/j.jfma.2024.03.001","DOIUrl":"10.1016/j.jfma.2024.03.001","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0929664624001463/pdfft?md5=3d2fecbeee0cf6ac7fea6b1fd064dcfc&pid=1-s2.0-S0929664624001463-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140059730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Copyright transfer statement 版权转让声明
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.1016/S0929-6646(24)00376-0
{"title":"Copyright transfer statement","authors":"","doi":"10.1016/S0929-6646(24)00376-0","DOIUrl":"10.1016/S0929-6646(24)00376-0","url":null,"abstract":"","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0929664624003760/pdfft?md5=5dc9dbef9fedf4894071e4304cc4625e&pid=1-s2.0-S0929664624003760-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142157971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An optimization model for reducing thrombectomy center rotations while maintaining medical accessibility 在保持医疗可及性的同时减少血栓切除中心轮转的优化模型。
IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-09-01 DOI: 10.1016/j.jfma.2024.04.007

Background/purpose

This study addresses the delicate balance between healthcare personnel burnout and medical accessibility in the context of endovascular thrombectomy (EVT) services in urban areas. We aimed to determine the minimum number of hospitals providing EVT on rotation each day without compromising patient access.

Methods

Employing an optimization model, we developed shift schedules based on patient coverage rates and volumes during the pre-pandemic (2016–2018) and pandemic (2019–2021) periods. Starting with a minimum of two hospitals on duty per day, we gradually increased to a maximum of eight. Patient coverage rates, defined as the proportion of patients meeting bypass criteria and transported to rotating hospitals capable of EVT, were the primary outcomes. Sensitivity analyses explored the impact of varying patient transport intervals and accumulating patients over multiple years.

Results

Results from 7024 patient records revealed patient coverage rates of 92.5% (standard deviation [SD] 2.8%) during the pre-pandemic and 91.4% (SD 2.8%) during the pandemic, with at least two rotating hospitals daily. No significant differences were observed between schedules based on the highest patient volume and coverage rate months. A patient coverage rate of 98.99% was achieved with four rotating hospitals per day during the pre-pandemic period, with limited improvement beyond this threshold. Changing patient transport intervals and accumulating patients over six years (p = 0.83) had no significant impact on coverage rates.

Conclusion

Our optimization model supports reducing the number of daily rotating hospitals by half while preserving a balance between patient accessibility and alleviating strain on medical teams.

背景/目的本研究探讨了城市地区血管内血栓切除术(EVT)服务中医护人员职业倦怠与医疗可及性之间的微妙平衡。我们旨在确定在不影响患者就医的情况下,每天至少有多少家医院轮流提供 EVT。方法我们采用优化模型,根据大流行前(2016-2018 年)和大流行期间(2019-2021 年)的患者覆盖率和数量制定了轮班时间表。从每天至少有两家医院值班开始,我们逐渐增加到最多八家医院。患者覆盖率是指符合分流标准并被送往具备 EVT 能力的轮转医院的患者比例,这是主要结果。结果7024 份患者记录显示,在大流行前和大流行期间,患者覆盖率分别为 92.5%(标准差 [SD] 2.8%)和 91.4%(标准差 2.8%),每天至少有两家轮转医院。根据病人数量最多的月份和覆盖率最高的月份,各时间表之间没有观察到明显的差异。在大流行前期,每天四家轮转医院的病人覆盖率达到 98.99%,超过这一临界值后,覆盖率的提高幅度有限。结论:我们的优化模型支持将每日轮转医院的数量减少一半,同时保持患者就医便利性与减轻医疗团队压力之间的平衡。
{"title":"An optimization model for reducing thrombectomy center rotations while maintaining medical accessibility","authors":"","doi":"10.1016/j.jfma.2024.04.007","DOIUrl":"10.1016/j.jfma.2024.04.007","url":null,"abstract":"<div><h3>Background/purpose</h3><p>This study addresses the delicate balance between healthcare personnel burnout and medical accessibility in the context of endovascular thrombectomy (EVT) services in urban areas. We aimed to determine the minimum number of hospitals providing EVT on rotation each day without compromising patient access.</p></div><div><h3>Methods</h3><p>Employing an optimization model, we developed shift schedules based on patient coverage rates and volumes during the pre-pandemic (2016–2018) and pandemic (2019–2021) periods. Starting with a minimum of two hospitals on duty per day, we gradually increased to a maximum of eight. Patient coverage rates, defined as the proportion of patients meeting bypass criteria and transported to rotating hospitals capable of EVT, were the primary outcomes. Sensitivity analyses explored the impact of varying patient transport intervals and accumulating patients over multiple years.</p></div><div><h3>Results</h3><p>Results from 7024 patient records revealed patient coverage rates of 92.5% (standard deviation [SD] 2.8%) during the pre-pandemic and 91.4% (SD 2.8%) during the pandemic, with at least two rotating hospitals daily. No significant differences were observed between schedules based on the highest patient volume and coverage rate months. A patient coverage rate of 98.99% was achieved with four rotating hospitals per day during the pre-pandemic period, with limited improvement beyond this threshold. Changing patient transport intervals and accumulating patients over six years (<em>p</em> = 0.83) had no significant impact on coverage rates.</p></div><div><h3>Conclusion</h3><p>Our optimization model supports reducing the number of daily rotating hospitals by half while preserving a balance between patient accessibility and alleviating strain on medical teams.</p></div>","PeriodicalId":17305,"journal":{"name":"Journal of the Formosan Medical Association","volume":null,"pages":null},"PeriodicalIF":2.6,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0929664624002079/pdfft?md5=0350657825ce8f29141ec802b58b5b94&pid=1-s2.0-S0929664624002079-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140797655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Formosan Medical Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1